These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


215 related items for PubMed ID: 10462828

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
    Bhatta-Dhar N, Reuther AM, Zippe C, Klein EA.
    Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
    DiMarco DS, Zincke H, Sebo TJ, Slezak J, Bergstralh EJ, Blute ML.
    J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison.
    Ghavamian R, Bergstralh EJ, Blute ML, Slezak J, Zincke H.
    J Urol; 1999 Apr; 161(4):1223-7; discussion 1227-8. PubMed ID: 10081874
    [Abstract] [Full Text] [Related]

  • 9. Limited pelvic lymph node dissection does not improve biochemical relapse-free survival at 10 years after radical prostatectomy in patients with low-risk prostate cancer.
    Weight CJ, Reuther AM, Gunn PW, Zippe CR, Dhar NB, Klein EA.
    Urology; 2008 Jan; 71(1):141-5. PubMed ID: 18242383
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Open pelvic lymph node dissection for prostate cancer: a reassessment.
    Campbell SC, Klein EA, Levin HS, Piedmonte MR.
    Urology; 1995 Sep; 46(3):352-5. PubMed ID: 7544933
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome.
    De La Roca RL, Da Cunha IW, Bezerra SM, Da Fonseca FP.
    Int Braz J Urol; 2014 Sep; 40(3):306-15. PubMed ID: 25010296
    [Abstract] [Full Text] [Related]

  • 14. Early surgical results with intent to treat by radical retropubic prostatectomy for clinically localized prostate cancer.
    Abbas F, Siddiqui K, Biyabani SR, Hasan SH, Talati J.
    J Pak Med Assoc; 2002 May; 52(5):200-5. PubMed ID: 12174491
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era.
    Dorin RP, Lieskovsky G, Fairey AS, Cai J, Daneshmand S.
    Urol Oncol; 2013 Nov; 31(8):1441-7. PubMed ID: 22516714
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.